Option Care Health (NASDAQ:OPCH) Given New $40.00 Price Target at JPMorgan Chase & Co.

Option Care Health (NASDAQ:OPCH) had its price objective lifted by JPMorgan Chase & Co. from $38.00 to $40.00 in a report released on Friday,Benzinga reports. They currently have an overweight rating on the stock.

Other analysts have also recently issued reports about the company. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price for the company. Barrington Research boosted their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a report on Tuesday, January 14th. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $35.00 in a research report on Thursday. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $32.25.

Option Care Health Stock Performance

Shares of OPCH stock opened at $30.33 on Friday. The firm has a market capitalization of $5.16 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 2.11 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The business’s 50-day moving average price is $24.26 and its 200-day moving average price is $27.80. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction on Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

A number of hedge funds have recently bought and sold shares of OPCH. UMB Bank n.a. raised its position in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC increased its stake in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its position in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the last quarter. International Assets Investment Management LLC lifted its position in Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after purchasing an additional 2,757 shares during the last quarter. Finally, Quarry LP boosted its stake in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after purchasing an additional 2,628 shares during the period. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.